Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Crook

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Investigative Dermatology|March 20, 1999
Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomasJ M McGregor, T Crook, E A Fraser-Andrews, et al.
Italian Journal of Neurological Sciences|April 1, 1995
Aging and memory: corrections for age, sex and education for three widely used memory testsG Zappalà, G Measso, F Cavarzeran, et al.
International Journal of Surgical Pathology|August 2, 2003
Distinct genetic and epigenetic changes in medullary breast cancerP Osin, Y-J Lu, J Stone, et al.
Oncogene|February 12, 1998
p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus statusJ M McGregor, R J Berkhout, M Rozycka, et al.
Journal of the American Academy of Dermatology|May 1, 1994
Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomavirusesJ M McGregor, A Farthing, T Crook, et al.
International Psychogeriatrics|January 1, 1991
Proposed factor structure of the Geriatric Depression ScaleJ I Sheikh, J A Yesavage, J O Brooks, et al.
British Journal of Cancer|April 17, 2008
Promoter hypermethylation of FANCF and outcome in advanced ovarian cancerS L Lim, P Smith, N Syed, et al.
Blood|March 15, 1997
p53 abnormalities in B-cell prolymphocytic leukemiaD Lens, P J De Schouwer, R A Hamoudi, et al.
Oncogene|June 29, 2001
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elementsP Campomenosi, P Monti, A Aprile, et al.
British Journal of Cancer|January 12, 2012
The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancerH M Coley, N A M Safuwan, P Chivers, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Investigative Dermatology|March 20, 1999
Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomasJ M McGregor, T Crook, E A Fraser-Andrews, et al.
Italian Journal of Neurological Sciences|April 1, 1995
Aging and memory: corrections for age, sex and education for three widely used memory testsG Zappalà, G Measso, F Cavarzeran, et al.
International Journal of Surgical Pathology|August 2, 2003
Distinct genetic and epigenetic changes in medullary breast cancerP Osin, Y-J Lu, J Stone, et al.
Oncogene|February 12, 1998
p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus statusJ M McGregor, R J Berkhout, M Rozycka, et al.
Journal of the American Academy of Dermatology|May 1, 1994
Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomavirusesJ M McGregor, A Farthing, T Crook, et al.
International Psychogeriatrics|January 1, 1991
Proposed factor structure of the Geriatric Depression ScaleJ I Sheikh, J A Yesavage, J O Brooks, et al.
British Journal of Cancer|April 17, 2008
Promoter hypermethylation of FANCF and outcome in advanced ovarian cancerS L Lim, P Smith, N Syed, et al.
Blood|March 15, 1997
p53 abnormalities in B-cell prolymphocytic leukemiaD Lens, P J De Schouwer, R A Hamoudi, et al.
Oncogene|June 29, 2001
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elementsP Campomenosi, P Monti, A Aprile, et al.
British Journal of Cancer|January 12, 2012
The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancerH M Coley, N A M Safuwan, P Chivers, et al.
Pageof 14